confirm
case
mer
death
casefat
rate
report
countri
world
health
organ
case
link
directli
indirectli
countri
middl
east
ksa
qatar
jordan
unit
arab
emir
uae
oman
tunisia
five
countri
outsid
middl
eastth
unit
kingdom
franc
itali
germani
tunisiahav
report
patient
either
transfer
care
return
visit
middl
east
subsequ
becam
ill
four
countriesitali
franc
tunisia
unit
kingdomhav
secondari
case
link
initi
import
case
major
merscov
case
date
case
report
ksa
occur
famili
hospit
cluster
sporad
commun
case
detect
mild
diseas
asymptomat
infect
screen
healthcar
worker
contact
mer
case
humantohuman
transmiss
merscov
well
document
ksa
england
franc
tunisia
itali
cluster
detect
far
mostli
small
report
sustain
transmiss
merscov
within
commun
despit
sever
multicountri
collabor
research
effort
govern
ksa
defin
demograph
clinic
featur
mode
transmiss
epidemiolog
famili
hospit
cluster
sever
import
prioriti
research
question
remain
unansw
unclear
primari
sourc
primari
mode
transmiss
merscov
human
iscrit
inform
essenti
develop
intervent
reduc
risk
transmiss
defin
epidemiolog
develop
effect
control
measur
cellular
receptor
merscov
identifi
dipeptidyl
peptidas
structur
receptorbind
domain
viru
spike
protein
complex
rapidli
identifi
receptor
conserv
across
mammal
suggest
sever
anim
host
although
definit
anim
reservoir
merscov
identifi
studi
merscov
genom
mer
case
suggest
exist
direct
anim
reservoir
merscov
bat
usual
suspect
transmiss
coronavirus
recent
studi
identifi
small
sequenc
merscov
maximum
possibl
ident
fecal
sampl
egyptian
tomb
bat
serolog
studi
anim
detect
antibodi
spike
protein
betacoronavirus
find
led
research
conclud
mer
time
pass
camel
support
theori
come
detect
antimerscov
antibodi
camel
oman
spain
author
studi
conclud
merscov
viru
similar
merscov
wide
circul
among
camel
oman
howev
provid
definit
proof
camel
sourc
merscov
viral
nucleic
acid
test
serum
fecal
sampl
reveal
presenc
merscov
viral
particl
furthermor
one
mer
case
report
oman
border
ksa
coronavirus
constitut
larg
famili
virus
may
caus
rang
ill
human
well
number
diseas
varieti
anim
previou
studi
shown
exampl
coronavirus
caus
sever
symptom
newborn
camel
may
like
crossreact
antibodi
relat
coronaviru
merscov
occur
research
requir
identifi
specif
sourc
reservoir
merscov
intermedi
anim
host
inanim
food
sourc
mode
transmiss
human
despit
studi
indic
presenc
antimerscov
antibodi
widespread
within
anim
popul
middl
east
human
studi
shown
widespread
infect
local
popul
articl
asad
aburizazaiza
colleagu
issu
journal
infecti
diseas
contain
data
studi
stage
approach
util
immunofluoresc
assay
ifa
differenti
recombin
ifa
plaqu
reduct
serum
neutral
assay
use
detect
merscov
antibodi
serum
sampl
blood
donor
abbatoir
worker
jeddah
makkah
hajj
pilgrimag
conclud
evid
merscov
circul
region
suggest
larg
percentag
popul
consid
nonimmun
although
data
appear
concord
appar
absenc
merscov
screen
reversetranscript
polymeras
chain
reaction
french
pilgrim
return
hajj
antibodi
studi
provid
proof
absenc
presenc
merscov
limit
impos
restrict
studi
design
small
number
studi
sever
group
develop
rang
serolog
test
detect
merscov
need
independ
evalu
valid
sensit
specif
assay
blind
panel
serum
sampl
known
posit
neg
mer
case
test
identifi
presenc
merscovspecif
nucleic
acid
avail
accur
valid
sensit
specif
serolog
test
essenti
conduct
casecontrol
studi
crucial
accur
defin
epidemiolog
potenti
impact
merscov
outbreak
surveil
purpos
mani
import
question
merscov
remain
unansw
natur
histori
pathogenesi
host
suscept
factor
viral
virul
viral
kinet
period
infecti
underli
mechan
protect
immun
optim
treatment
factor
govern
treatment
outcom
remain
unclear
absenc
basic
data
hinder
develop
drug
treatment
adjunct
therapi
specif
diagnost
biomark
vaccin
wherea
anim
sourc
viru
appear
like
sourc
rout
transmiss
could
either
direct
indirect
contact
consumpt
contamin
food
food
product
avail
data
indic
merscov
yet
readili
adapt
infect
human
humantohuman
transmiss
suffici
effici
pandem
potenti
despit
extens
investig
screen
test
contact
mer
case
ksa
instanc
transmiss
identifi
healthcar
worker
postmortem
histolog
studi
avail
introduc
even
noninvas
autopsi
would
help
advanc
scientif
knowledg
base
avail
anim
model
merscov
infect
diseas
essenti
understand
pathogenesi
natur
histori
immun
respons
develop
effect
therapi
issu
journal
tanfeng
yao
colleagu
describ
anim
model
mer
produc
use
intratrach
infect
rhesu
macaqu
monkey
merscov
result
develop
pneumonia
show
merscov
replic
larg
restrict
lowerrespiratori
tract
infect
monkey
show
clinic
sign
diseas
viru
replic
histolog
chang
neutral
antibodi
product
anoth
recent
studi
rhesu
macaqu
monkey
model
merscov
infect
shown
similar
find
use
combin
intratrach
ocular
oral
intranas
inocul
tissu
cultur
infecti
dose
merscov
isol
monkey
develop
transient
lowerrespiratorytract
infect
clinic
sign
viru
shed
viru
replic
respiratori
tissu
gene
express
cytokin
chemokin
profil
peak
earli
infect
decreas
time
merscov
caus
mild
mark
multifoc
interstiti
pneumonia
merscov
replic
occur
mainli
alveolar
pneumocyt
tropism
merscov
lowerrespiratori
tract
may
explain
sever
diseas
observ
human
limit
humantohuman
transmiss
merscov
rhesu
macaqu
model
instrument
develop
test
vaccin
treatment
option
emerg
viral
pathogen
pandem
potenti
specif
therapeut
intervent
merscov
avail
clinic
evalu
current
patient
manag
reli
exclus
support
care
given
high
casefat
rate
record
far
highli
effect
empir
treatment
antivir
drug
drug
regimen
immun
therapi
use
sever
acut
respiratori
syndrom
sar
requir
clinic
evalu
recent
studi
indic
combin
may
effect
merscov
use
small
compoundbas
forward
chemic
genet
screen
known
drug
influenza
also
interferon
nelfinavir
lopinavir
nitazoxanid
report
anticoronaviru
effect
author
identifi
mycophenol
acid
ribavirin
interferon
exhibit
vitro
antimerscov
activ
show
antivir
effect
stronger
ribavirin
use
rhesu
macaqu
monkey
model
merscov
infect
falzarano
et
al
show
treatment
ribavirin
reduc
viru
replic
moder
host
respons
improv
clinic
outcom
clinic
evalu
ribavirin
consid
sever
case
mer
treatment
option
merscov
requir
investig
includ
cyclophilin
inhibitor
convalesc
plasma
patient
fulli
recov
merscov
convalesc
plasma
relat
hyperimmun
globulin
may
appar
success
sar
influenza
pandem
due
influenza
viru
current
knowledg
gap
unknown
whether
merscov
remain
diseas
restrict
middl
east
intermitt
sporad
outbreak
progress
becom
global
pandem
burn
time
mani
prioriti
research
question
remain
answer
true
pandem
potenti
global
impact
merscov
accur
determin
almost
patient
die
hospit
sever
diseas
comorbid
medic
condit
mortal
rate
sever
diseas
exagger
degre
detect
case
casefat
rate
fallen
recent
month
due
detect
milder
asymptomat
case
determin
true
spectrum
merscov
infect
diseas
sever
requir
widespread
viral
test
collect
clinic
data
serolog
studi
casecontrol
studi
essenti
defin
merscov
outbreak
valid
accur
serolog
test
sensit
specif
requir
facilit
omin
characterist
pandem
merscov
strain
would
progress
effici
humantohuman
transmiss
number
sporad
mer
case
report
small
indic
viru
appear
readili
capabl
rapid
humantohuman
transmiss
despit
extens
investig
test
hundr
contact
ksa
ministri
health
instanc
transmiss
healthcar
worker
famili
contact
identifi
sequenc
studi
merscov
genom
may
reveal
genet
featur
tell
us
merscov
abil
mutat
spread
effici
rapid
share
genet
sequenc
inform
provid
valuabl
insight
understand
molecular
characterist
transmiss
dynam
assist
defin
speci
specif
ascertain
mutat
rate
virul
also
enabl
discoveri
drug
target
novel
drug
diagnost
vaccin
two
million
pilgrim
countri
million
local
ksa
pilgrim
recent
visit
makkah
madinah
ksa
perform
annual
hajj
pilgrimag
return
home
stay
week
million
other
visit
ksa
throughout
year
minipilgrimag
umrah
answer
prioriti
research
merscov
sought
need
coordin
surveil
improv
effect
intern
cooper
middl
eastern
govern
academ
stakehold
pharmaceut
compani
remain
critic
tackl
omin
threat
rather
disconcert
major
knowledg
gap
remain
current
merscov
outbreak
year
first
discoveri
illustr
remain
dire
need
establish
robust
public
health
clinic
infrastructur
effect
global
consortia
stabl
fund
sourc
rapid
effect
definit
new
infecti
diseas
outbreak
threat
priorit
research
prepared
respons
effort
